首页> 美国政府科技报告 >Use of Nifedipine in the Treatment of Thrombosis
【24h】

Use of Nifedipine in the Treatment of Thrombosis

机译:硝苯地平治疗血栓形成的应用

获取原文

摘要

The report shows that arterial and venous thrombosis are accompanied by an abnormality in Ca2+ handling by the platelets. The abnormality is readily detectable in tests using the fluorescent chelate probe chlorotetracycline. The tests show that the Ca2+ level in the dense tubules of the platelets collected from thrombosis patients are greatly elevated compared to normal controls. The patients also showed a greater extent of Ca2+ release from the dense tubules to the cytoplasm when their platelets were stimulated by collegen. Administration of the Ca2+ channel blocker nifedipine (Procardia(R)) at 10 mg three times per day reduced the values of dense tubule-associated and collagen-releasable Ca2+ to normal values. This treatment is accompanied by improvement of clinical symptoms in all cases. A mechanism is proposed to explain this therapeutic effect.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号